GCG and Parkinson disease: Moreover, glycation is associated with motor, cognitive, and olfactory dysfunction [85], which is very common in PD, suggesting that anti-diabetic medications like GLP-1 (glucagon-like peptide 1) antagonists can help modify the neurodegenerative course of PD [100].